 ImmuCell NASDAQ: ICCC is one of 25 public companies in the Diagnostic substances industry, but how does it weigh in compared to its competitors? We will compare ImmuCell to related companies based on the strength of its earnings, valuation, analyst recommendations, institutional ownership, profitability, risk and dividends. Analyst Recommendations This is a summary of current ... 